Status | Study |
Not yet recruiting |
Study Name: Continuous Pre-peritoneal Wound Infiltration Versus Epidural Analgesia in Cancer Surgery Condition: Abdominal Neoplasms Date: 2016-12-19 Interventions: Device: epidural catheter Othe |
Recruiting |
Study Name: Intraperitoneal Infusion of Autologous Monocytes With Sylatron (Peginterferon Alfa-2b) and Actimmune (Interferon Gamma-1b) in Women With Recurrent or Refractory Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer Condition: Fallopian Tube Cancer Ovarian Cancer Primary Peritoneal Ca Date: 2016-10-27 Interventions: Biological: Autologous Monocytes + ACTIMMUNE + SYLATRON The autologous monocytes cell product in 250ml t |
Recruiting |
Study Name: Evaluation of Pcv-aCO2 in the Fluid Treatment of Abdominal Tumor Patients After Surgery Condition: Abdominal Tumor Abdominal Infection Date: 2016-10-09 Interventions: Other: standardized fluid therapy |
Active, not recruiting |
Study Name: Effect of Wound Infiltration by Ketamine Versus Dexmedetomidine Added to Bupivacaine on Surgical Stress Condition: Abdominal Cancer Date: 2016-10-05 Interventions: Drug: Dexmedetomidine local an |
Recruiting |
Study Name: Phase I Study of Cantrixil in Patients With Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer. Condition: Ovarian Neoplasms Fallopian Tube Neoplasms Peritoneal Neop Date: 2016-09-12 Interventions: Drug: Part A: Dose Escalation of Cantrixil |
Recruiting |
Study Name: A Phase II Study Of Nivolumab/ Bevacizumab Condition: Peritoneal Cancer Ovarian Cancer Fallopian Tube Cancer Date: 2016-08-17 Interventions: Drug: Bevacizumab |
Recruiting |
Study Name: Pembrolizumab Combined With PLD For Recurrent Platinum Resistant Ovarian, Fallopian Tube Or Peritoneal Cancer Condition: Ovarian Cancer Fallopian Tube Cancer Peritoneal Cancer Date: 2016-08-10 Interventions: Drug: Pembrolizumab Please see |
Not yet recruiting |
Study Name: PET Imaging of Ovarian Carcinoma With 18F-FSPG Condition: Stage IIIA Fallopian Tube Cancer Stage IIIA Ovarian Cancer Date: 2016-07-26 Interventions: Radiation: (S)-4-(3-[18F]Fluoropropyl)-L-glutamic acid (18F-FSPG) |
Recruiting |
Study Name: ARIEL4: A Study of Rucaparib Versus Chemotherapy BRCA Mutant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients Condition: Ovarian Cancer Epithelial Ovarian Cancer Fallopian Tube Ca Date: 2016-07-22 Interventions: Drug: Chemotherapy Chemotherap |
Not yet recruiting |
Study Name: Sirolimus and Vaccine Therapy in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Condition: Recurrent Fallopian Tube Carcinoma Recurrent Ovarian Carcinoma Date: 2016-07-08 Interventions: Other: Laboratory Biomarker Analysis |